Activating GLP-1 receptors has been shown to aid weight loss, glycemic control, cardiovascular health, liver health, neurological function, and more
Estudio con ajuste de dosis flexible: En un estudio abierto de 52 semanas, se aleatorizaron 504 pacientes con diabetes tipo 2 para ser tratados con semaglutida (ajuste flexible de dosis de 3 mg, 7 mg y 14 mg una vez al da) o 100 mg de sitagliptina una vez al da, todas en combinacin con 1 o 2 medicamentos hipoglucemiantes orales (metformina, inhibidores del SGLT2, sulfonilurea o tiazolidinedionas)
Regina Castro of the Mayo Clinic wrote in an article for the institution's website that it is not yet certain why GLP-1 agonists help with weight loss, but they do curb hunger and can make a person eat less
Keshari AK, Srivastava R, Singh P, Yadav VB, Nath G (2020) Antioxidant and antibacterial activity of silver nanoparticles synthesized by Cestrum nocturnum